ÐÓ°ÉÔ­´´

Opencell's approach of converting shipping containers into biotech lab spaces has significant potential to make biotechnology more accessible and affordable. Based in London, the company operates on a B2B SaaS model, serving various sectors. By repurposing shipping containers, Opencell addresses challenges faced by traditional lab spaces, such as high construction costs and limited accessibility. This solution can democratize access to advanced biotech facilities, fostering innovation and lowering barriers for smaller companies and research teams. Supported by Seventure Partners, Opencell is positioned to disrupt the market by providing a cost-effective and flexible alternative to conventional lab facilities.